SYSTEMS GENETICS TO DETERMINE RISK OF DEVELOPING DIABETES COMPLICATIONS
Emeritus Professor Grant Morahan, Professor of Diabetes Research, University of Western Australia Centre for Medical Research (affiliated with the Harry Perkins Institute of Medical Research), Perth, Australia & Honorary Professor, Baker Department of Cardiometabolic Health, University of Melbourne, Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | December 2025
Professor Morahan invented the term “Systems Genetics” for the science field that examines how genetic variants can affect whole networks of genes and whole systems; there are now several laboratories and institutes of systems genetics around the world. He also developed the next-generation genetic resource, The Gene Mine, the most powerful of its type in the world, used globally in rapid mapping and identification of genes. Collaborators nationally and internationally have tested The Gene Mine for traits and diseases in which they specialise.
As a member of the Steering Committee of the Type 1 Diabetes Genetics Consortium, he worked to design the global study recruiting and characterising T1D genetics, which resulted in identification of over 40 T1D risk genes. The culmination of this program, for which Prof Morahan was PI of the Asia-Pacific Network, was published in Nature Genetics (41:703-707) and has been cited 1579 times.
Currently, he is a member of the Steering Committee of the Environmental Determinants of Islet Autoimmunity (ENDIA) Study, the only study in the world investigating T1D families to follow at-risk babies from pregnancy through childhood. Completing recruitment in 2020, the study already has 40 publications.
His latest discovery involves next-generation algorithms that are able to predict whether a person will be genetically high/low risk of developing a number of complex genetic diseases. Professor Morahan is working toward commercialising these genetic tests so they can benefit the public and the healthcare system.
During his career, Prof Morahan has supervised 23 postgraduate students and mentored nine postdoctoral positions. Since 2003, Prof Morahan has applied for and received close to $20 million in research funds, both nationally and internationally. He has 299 academic publications, 17,0744 citations and has an h-index of 60.
Source: Supplied
https://orcid.org/0000-0002-8562-7325
-
Exercise therapy for metabolic dysfunction-associated steatotic liver disease
Dr Shelley Keating is a Senior Lecturer in Clinical Exercise Physiology and Accredited Exercise Physiologist from the School of Human Movement and Nutrition Sciences at the University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating’s research centres on the utility of exercise as a therapy for obesity and related cardiometabolic conditions, notably metabolic dysfunction-associated steatotic liver disease (MASLD).
-
Paramedics in the Community
Dr Brendan Shannon is a registered paramedic and Head of Postgraduate Programs and Deputy Head of Department of Paramedicine at Monash University.
Brendan has a keen research interest in alternative care pathways, non-transport, referral services, paramedic practitioners and community paramedicine. His Doctoral research focused on investigating the experiences of health services when implementing alternative care pathways.
-
Therapy to prevent hepatocellular carcinoma in people with liver cirrhosis
Professor John Olynyk is a Gastroenterologist & Hepatologist with over 30 years’ experience, primarily at The Fiona Stanley & Fremantle Hospital Group. He planned the Gastroenterology and Hepatology Service for the Fiona Stanley Hospital and was Head Department from 2010 until 2020.
Professor John Olynyk was appointed as Associate Dean and Head of the Medical Discipline at Curtin University in 2023 until 2025 and is now Associate Director, Clinical Engagement, Curtin Medical Research Institute, Curtin University.
